SPECIAL REPORT
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- US Home Prices Up 5th Month, 2nd Straight Quarter
- China Eastern to Complete Shanghai Air Buy by End '09
- Gold Will Collapse Like Oil Did in 2008: Charts
- Wave of Debt Payments Facing US Government
- Weak Dollar Is Golden for Mining Companies
- Revised GDP Reading Puts Growth at 2.8%; Inflation Tame
- FDIC Insurance Fund Falls to Negative $8.2 Billion
- GM's Plan to Sell Saab Unit To Swedish Firm Falls Apart
- The Lloyd's Prayer, Leggo My Eggo, Plate Hate & Your Emails
- Buy These 'Competitively Positioned' Stocks: Portfolio Manager
- Behind The Scenes With Warren Buffett
- 'Why the American Consumer Will Keep on Buying No Matter What'
- On Assignment: Europe & Asia
- The L.A. Extravaganza: A Test for Auto Shows
- 8 Stocks That Could Gain With Rising GDP
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- Can Murdoch Help Bing Challenge Google and Shift the Content Equation?
- Consumer Confidence Improves But Still Shaky
- US Home Prices Up 5th Month, 2nd Straight Quarter
- Revised GDP Reading Puts Growth at 2.8%; Inflation Tame
- FDIC Insurance Fund Falls to Negative $8.2 Billion
- Ron Paul's Plan to Audit Fed a 'Serious Attack': Mishkin
- US Economy Mired in 'Form of Depression': Rosenberg
- Strong Banks, Weak Credit: Treasury Rethinks TARP
- Fairfax Lawsuit Keeps Heat on Chanos, SAC's Cohen
- Blog: Behind The Scenes With Warren Buffett
PHARMA'S MARKET VIDEO

Novartis Opens 1st US Plant for Flu Vaccine
4 hrs ago
Cholesterol Drug Battle: Niaspan vs. Zetia
16 Nov 2009
Cardiologist Grades Cholesterol Drug Study
16 Nov 2009
Merck's Cholesterol Drugs Under Pressure
16 Nov 2009
Cholesterol Drug Battle: Merck vs. Abbott Labs
16 Nov 2009
Cholesterol Drug Battle
16 Nov 2009
RSS FEED
Pharma's Market
On the day that industry nemesis Rep. Henry Waxman wins a power play in Washington and the day after another pharma foe, former Democratic Senator Tom Daschle, is picked by President-elect Obama to be Secretary of Health and Human Services, drug giant Merck is wasting no time trying to head them all off at the pass.
In full-page ads in major newspapers today, the Dow component is fashioning itself as a compassionate drug company. The big, boldface type says, "In these challenging times, Merck is here to help." 
The fine-print text then goes on to detail Merck's [MRK
Loading...
()
] commitment to making sure that people who don't have insurance or who can't afford their prescription drugs can get them for free or at a discount. It also directs people to a web site called "MerckHelps.com."
But the ad is really aimed just as much, if not more so, at Obama, Waxman and Daschle than it is to needy patients. A key paragraph begins, "HEALTHCARE FOR ALL." The caps and boldface type are Merck's not mine. Then the copy says, "Merck supports reform of our healthcare system to ensure that all Americans have affordable access to quality healthcare coverage, including medicines and vaccines. We pledge to work with the new administration and Congress to support the enactment of common-sense plans to expand coverage, improve quality and ensure that we all get good value for our healthcare dollars."
I think the most crucial words in that sentence are "common-sense."
I wonder if this is just the beginning of the major drug companies extending olive branches, jockeying for a place at the table in the new Washington; and attempting to polish up their images as they brace for what many analysts believe could be a flurry of hearings and proposed legislation that puts pharma in the crosshairs.
Questions? Comments?








